Inc424


Indications and Reactions:

Role Indications Reactions
Primary
Myelofibrosis 79.0%
Prophylaxis 2.8%
Constipation 2.4%
Hypertension 2.4%
Cancer Pain 1.2%
Oedema Peripheral 1.2%
Polycythaemia 1.2%
Polycythaemia Vera 1.2%
Acute Febrile Neutrophilic Dermatosis 0.8%
Atrial Fibrillation 0.8%
Back Pain 0.8%
Headache 0.8%
Inflammation 0.8%
Insomnia 0.8%
Oedema 0.8%
Platelet Count Decreased 0.8%
Splenomegaly 0.8%
Alanine Aminotransferase Increased 0.4%
Arthralgia 0.4%
Chromosome Analysis Abnormal 0.4%
Pneumonia 8.3%
Death 7.1%
Renal Failure Acute 7.1%
Respiratory Failure 7.1%
Sepsis 7.1%
Thrombocytopenia 6.0%
Tumour Lysis Syndrome 6.0%
Anaemia 4.8%
Cardiac Failure 4.8%
Hyperuricaemia 4.8%
Visual Impairment 4.8%
Abdominal Wall Haematoma 3.6%
Gastroenteritis 3.6%
Left Ventricular Dysfunction 3.6%
Nausea 3.6%
Pancytopenia 3.6%
Pyrexia 3.6%
Septic Shock 3.6%
Thrombocytosis 3.6%
Vertigo 3.6%
Secondary
Myelofibrosis 32.8%
Cancer Pain 8.9%
Constipation 8.0%
Hypertension 6.7%
Insomnia 5.4%
Platelet Count Decreased 3.9%
Haemochromatosis 3.5%
Neuropathy Peripheral 3.5%
Oedema Peripheral 3.5%
Prophylaxis Against Gastrointestinal Ulcer 3.5%
Arthralgia 3.2%
Headache 2.7%
Prophylaxis 2.5%
Acute Febrile Neutrophilic Dermatosis 2.3%
Hyperuricaemia 2.0%
Herpes Zoster 1.8%
Iron Overload 1.5%
Polycythaemia Vera 1.5%
Dermatitis 1.3%
Dizziness 1.3%
Renal Failure Acute 12.9%
Herpes Zoster 9.5%
Pneumonia 7.8%
Cardiac Failure 6.9%
Macular Degeneration 6.0%
Upper Respiratory Tract Infection 6.0%
Hyperuricaemia 5.2%
Impetigo 5.2%
Pyrexia 5.2%
Thrombocytopenia 5.2%
Gastroenteritis 4.3%
Multi-organ Failure 3.4%
Syncope 3.4%
Urinary Tract Infection 3.4%
Hepatitis B 2.6%
Nausea 2.6%
Neuropathy Peripheral 2.6%
Osteoporosis 2.6%
Pericardial Haemorrhage 2.6%
Splenic Rupture 2.6%

Drug Data